Form 4: AtriCure CEO Gifts 10,000 Shares

AtriCure's President and CEO, Michael H. Carrel, reported a charitable gift of 10,000 shares of common stock.

Summary

• Michael H. Carrel, President, CEO, and Director of AtriCure, Inc. (ATRC), disposed of 10,000 shares of common stock.
• The transaction, dated August 8, 2025, was a charitable gift, with no consideration received.
• Following the gift, Carrel directly beneficially owns 697,377 shares of common stock.
• Additionally, Carrel indirectly beneficially owns 9,310 shares through his children and 2,250 shares through his parents, disclaiming beneficial ownership except for pecuniary interest.

Sentiment

Score: 5

Explanation: A charitable gift by an insider is generally neutral to slightly positive for corporate image, but it represents a reduction in direct insider holdings. It does not reflect on operational performance.

Positives

• Demonstrates philanthropic activity by a key executive, potentially enhancing corporate social responsibility perception.

Negatives

• Reduces the direct equity stake of a key executive in the company by 10,000 shares.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it primarily reports a change in beneficial ownership.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide information related to broader industry trends or competitor activities.

Comparison to Industry Standards

• This filing details an individual insider stock transaction and does not contain information suitable for comparison to global benchmarks, comparable companies, projects, or results.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but the philanthropic nature could be viewed positively.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific transaction.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction (a charitable gift of shares) and does not contain information that would warrant a change in investment recommendation. It provides no new insights into the company's financial performance, strategic direction, or operational health that would influence a buy or sell decision. Therefore, a 'hold' recommendation is appropriate as the filing itself does not present a compelling reason to alter an existing position.

Keywords

AtriCure, ATRC, Michael H. Carrel, Insider Transaction, Form 4, Charitable Gift, Stock Ownership, CEO, Director